CCM
VTVT icon

Connective Capital Management’s vTv Therapeutics VTVT Stock Holding History

Connective Capital Management’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,712
Closed -$227K – 89
2025
Q3 		$227K Hold
9,712
– – 0.21% 55
2025
Q2 		$146K Buy
9,712
+335
+4% +$6.14K 0.14% 44
2025
Q1 		$162K Buy
+9,377
New +$157K 0.15% 38

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Connective Capital Management's VTVT Position: Q4 2025 in Review

Connective Capital Management sold out of vTv Therapeutics (VTVT) in Q4 2025, closing a stake of 9,712 shares — an estimated $227K sold.

Connective Capital Management first reported a position in VTVT in Q1 2025 and held it in 3 quarters. The position peaked at $227K in Q3 2025. 27 funds tracked by Wall St. Rank hold VTVT as of Q4 2025.

  • Connective Capital Management reported no remaining vTv Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Connective Capital Management sold 9,712 vTv Therapeutics shares in Q4 2025, an estimated $227K.
  • Connective Capital Management first reported a position in vTv Therapeutics in Q1 2025 and held it in 3 quarters.
  • Connective Capital Management's vTv Therapeutics position peaked at $227K in Q3 2025.
  • 27 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2025.

Based on Connective Capital Management's 13F filing for Q4 2025, filed 19 Feb 2026.